Ranibizumab: uses,side effects and Precautionary measures

Page 1

Ranibizumab: uses,side effects and Precautionary measures

Available as Lucentis in the market, Ranibizumab is a monoclonal antibody fragment. The parent mouse antibody from which it has been created is the same as that of Bevacizumab. Its anti-angiogenic activities are used for treating severe eye conditions like age-related macular degeneration, macular edema and diabetic retinopathy. Not only that, but it is also prescribed to patients to prevent blindness or decreased vision.

How is it given? Usage & Dosage The medication is given as an injection in the affected eye by experienced healthcare professional. Before giving it, the eye will be numbed by an agent so that the patient does not feel the pain. After giving it, they have to stay back at the hospital for a few hours so that the doctor can monitor the condition. In most cases, a single injection is given every month. However, there are exceptional circumstances where the injection may be administered once every 2 or 3 months. The treatment may be paused, or the dosages may be modified if there are unbearable toxicities. The typical doses are 0.5mg and 0.3mg.

Precautionary Measures 1. The eyes must be cleaned aseptically before giving the injection with betadine.


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
Ranibizumab: uses,side effects and Precautionary measures by Ikris Pharma - Issuu